摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

pantothenate-7-amino-4-methylcoumarin | 1224691-12-6

中文名称
——
中文别名
——
英文名称
pantothenate-7-amino-4-methylcoumarin
英文别名
pantothenate-7-amino-4-methylcoumarine;pAMC;(2R)-2,4-dihydroxy-3,3-dimethyl-N-[3-[(4-methyl-2-oxochromen-7-yl)amino]-3-oxopropyl]butanamide
pantothenate-7-amino-4-methylcoumarin化学式
CAS
1224691-12-6
化学式
C19H24N2O6
mdl
——
分子量
376.409
InChiKey
QMSSTHIQHBHLMP-KRWDZBQOSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    748.4±60.0 °C(Predicted)
  • 密度:
    1.320±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    0.1
  • 重原子数:
    27
  • 可旋转键数:
    7
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.42
  • 拓扑面积:
    125
  • 氢给体数:
    4
  • 氢受体数:
    6

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    pantothenate-7-amino-4-methylcoumarin 在 His/Flag-tagged human vanin-1 、 1,4-二巯基-2,3-丁二醇bovine serum albumin 作用下, 反应 1.0h, 生成 7-氨基-4-甲基香豆素D-泛酸
    参考文献:
    名称:
    A fluorescent assay suitable for inhibitor screening and vanin tissue quantification
    摘要:
    Vanin-1 is a pantetheinase that catalyzes the hydrolysis of pantetheine to produce pantothenic acid (vitamin B5) and cysteamine. Reported here is a highly sensitive fluorescent assay using a novel fluorescently labeled pantothenate derivative. The assay has been used for characterization of a soluble version of human vanin-1 recombinant protein, identification and characterization of hits from high-throughput screening (HTS), and quantification of vanin pantothenase activity in cell lines and tissues. Under optimized assay conditions, we quantified vanin pantothenase activity in tissue lysate and found low activity in lung and liver but high activity in kidney. We demonstrated that the purified recombinant vanin-1 consisting of the extracellular portion without the glycosylphosphatidylinositol (GPI) linker was highly active with an apparent K-m of 28 mu M for pantothenate-7-amino-4-methylcoumarin (pantothenate-AMC), which was converted to pantothenic acid and AMC based on liquid chromatography-mass spectrometry (LC-MS) analysis. The assay also performed well in a 384-well microplate format under initial rate conditions (10% conversion) with a signal-to-background ratio (S/B) of 7 and a Z factor of 0.75. Preliminary screening of a library of 1280 pharmaceutically active compounds identified inhibitors with novel chemical scaffolds. This assay will be a powerful tool for target validation and drug lead identification and characterization. (C) 2009 Elsevier Inc. All rights reserved.
    DOI:
    10.1016/j.ab.2009.12.010
  • 作为产物:
    描述:
    H-beta-丙氨酰-7-氨基-4-甲基香豆素三氟乙酸盐D-(-)-泛酰内酯乙醇 为溶剂, 反应 48.0h, 以32 mg的产率得到pantothenate-7-amino-4-methylcoumarin
    参考文献:
    名称:
    A fluorescent assay suitable for inhibitor screening and vanin tissue quantification
    摘要:
    Vanin-1 is a pantetheinase that catalyzes the hydrolysis of pantetheine to produce pantothenic acid (vitamin B5) and cysteamine. Reported here is a highly sensitive fluorescent assay using a novel fluorescently labeled pantothenate derivative. The assay has been used for characterization of a soluble version of human vanin-1 recombinant protein, identification and characterization of hits from high-throughput screening (HTS), and quantification of vanin pantothenase activity in cell lines and tissues. Under optimized assay conditions, we quantified vanin pantothenase activity in tissue lysate and found low activity in lung and liver but high activity in kidney. We demonstrated that the purified recombinant vanin-1 consisting of the extracellular portion without the glycosylphosphatidylinositol (GPI) linker was highly active with an apparent K-m of 28 mu M for pantothenate-7-amino-4-methylcoumarin (pantothenate-AMC), which was converted to pantothenic acid and AMC based on liquid chromatography-mass spectrometry (LC-MS) analysis. The assay also performed well in a 384-well microplate format under initial rate conditions (10% conversion) with a signal-to-background ratio (S/B) of 7 and a Z factor of 0.75. Preliminary screening of a library of 1280 pharmaceutically active compounds identified inhibitors with novel chemical scaffolds. This assay will be a powerful tool for target validation and drug lead identification and characterization. (C) 2009 Elsevier Inc. All rights reserved.
    DOI:
    10.1016/j.ab.2009.12.010
点击查看最新优质反应信息

文献信息

  • A fluorescent assay suitable for inhibitor screening and vanin tissue quantification
    作者:Benfang H. Ruan、Derek C. Cole、Paul Wu、Amira Quazi、Karen Page、Jill F. Wright、Nelson Huang、Joseph R. Stock、Karl Nocka、Ann Aulabaugh、Rustem Krykbaev、Lori J. Fitz、Neil M. Wolfman、Margaret L. Fleming
    DOI:10.1016/j.ab.2009.12.010
    日期:2010.4
    Vanin-1 is a pantetheinase that catalyzes the hydrolysis of pantetheine to produce pantothenic acid (vitamin B5) and cysteamine. Reported here is a highly sensitive fluorescent assay using a novel fluorescently labeled pantothenate derivative. The assay has been used for characterization of a soluble version of human vanin-1 recombinant protein, identification and characterization of hits from high-throughput screening (HTS), and quantification of vanin pantothenase activity in cell lines and tissues. Under optimized assay conditions, we quantified vanin pantothenase activity in tissue lysate and found low activity in lung and liver but high activity in kidney. We demonstrated that the purified recombinant vanin-1 consisting of the extracellular portion without the glycosylphosphatidylinositol (GPI) linker was highly active with an apparent K-m of 28 mu M for pantothenate-7-amino-4-methylcoumarin (pantothenate-AMC), which was converted to pantothenic acid and AMC based on liquid chromatography-mass spectrometry (LC-MS) analysis. The assay also performed well in a 384-well microplate format under initial rate conditions (10% conversion) with a signal-to-background ratio (S/B) of 7 and a Z factor of 0.75. Preliminary screening of a library of 1280 pharmaceutically active compounds identified inhibitors with novel chemical scaffolds. This assay will be a powerful tool for target validation and drug lead identification and characterization. (C) 2009 Elsevier Inc. All rights reserved.
查看更多